# DIBBS #SPE2DP-27-T-0217

DLA Request for Docusate Sodium Capsules

**Posted:** November 03, 2026
**Respond By:** November 09, 2026
**Identifier:** SPE2DP-27-T-0217
**NAICS:** 424210

DLA Troop Support is seeking a small delivery of prescription docusate sodium capsules for its Medical Supply Chain Pharmaceutical FSA.
- **Government buyer:** Defense Logistics Agency (DLA), DLA Troop Support, Medical Supply Chain Pharmaceutical FSA; contact listed: James Mariani.
- **Product:** 3 packages of docusate sodium capsules, USP, 10 mg, NSN 6505-00-163-7656; each package contains 100 unit doses.
- **Named approved sources:** The Harvard Drug Group, L.L.C. (P/N NDC00904-7183-61) and AmerisourceBergen Drug Corp. (P/N NDC60687-0129-01). The notice identifies them as approved sources, not necessarily as manufacturers.
- **Requirements:** Prescription-only product; store at 20–25°C (68–77°F), controlled room temperature. Delivery is FOB destination and required within 20 days after order.
- **Additional specifications:** None stated in the provided material.

### Description

DOCUSATE SODIUM CAPSUL (QTY: 3, NSN: 6505-00-163-7656, Purchase Request: 7018955368)
  Approved Sources:
  - CAGE: 1LEZ0, Part No: NDC00904-7183-61, Company: THE HARVARD DRUG GROUP, L.L.C.
  - CAGE: 1XUY5, Part No: NDC60687-0129-01, Company: AMERISOURCEBERGEN DRUG CORP
 

[View original listing](https://www.dibbs.bsm.dla.mil/rfq/rfqrec.aspx?sn=SPE2DP27T0217)